Stocks / AME vs AXON

AMETEK, Inc. (AME) vs Axovant Sciences Ltd. Common Shares (AXON)

AMETEK, Inc. and Axovant Sciences Ltd. Common Shares side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.

AME is the larger company ($54.9B vs $51.0B). On the fundamentals, AXON grows revenue faster (32.5% vs 10.3%); AME earns a higher net margin (20.0% vs 4.5%); AME has the stronger return on equity (13.9% vs 3.8%). Over the last five years, AXON returned 230.3% vs 79.5%. On the filings, AME carries fewer potential red flags (0 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — AME vs AXON, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 AMETEK, Inc. (AME)Axovant Sciences Ltd. Common Shares (AXON)
Market cap$54.9B$51.0B
Revenue (latest FY)$7.40B$2.78B
Net income (latest FY)$1.48B$124.66M
Revenue growth (5y CAGR)10.3%32.5%
Net margin20.0%4.5%
Return on equity13.9%3.8%
P/E ratio35.0262.7
Dividend yield0.6%
Profitable years (of last 10)108
Positive free cash flowYesYes

Performance — AME vs AXON

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 AMETEK, Inc. (AME)Axovant Sciences Ltd. Common Shares (AXON)
1-year return28.6%-19.6%
3-year return51.0%182.2%
5-year return79.5%230.3%
10-year return418.0%2118.4%
52-week range$179.24–$261.16$339.01–$792.16

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full AME vs AXON breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open AME's full financials →   Open AXON's full financials →

More comparisons

Frequently asked questions

Which is bigger, AME or AXON?

AMETEK, Inc. is larger by market capitalization — $54.9B versus $51.0B.

Which grows faster, AME or AXON?

Over the last five fiscal years, Axovant Sciences Ltd. Common Shares grew revenue faster — 32.5%/yr versus 10.3%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

AME fundamentals → · AXON fundamentals → · All 1,500+ companies → · Free screener →